Beibei Su
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 2
- Oncology 4
- HER2/EGFR in Cancer Research 2
- Cancer Cells and Metastasis 1
- Co-authors
- Xianglin Yuan (5 shared papers)Yu Tong Jin (3 shared papers)Han Yin (3 shared papers)Bili Wu (2 shared papers)Shuwei Zhou (5 shared papers)Hu Han (2 shared papers)Chaofan Liu (1 shared paper)Lu Wang (1 shared paper)
In The Last Decade
Beibei Su
14 papers receiving 431 citations
Peers
Comparison fields: 5 of 51
- Cancer Research 123
- Oncology 80
- Neurology 24
- Periodontics 18
- Pulmonary and Respiratory Medicine 68
Countries citing papers authored by Beibei Su
This map shows the geographic impact of Beibei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beibei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beibei Su more than expected).
Fields of papers citing papers by Beibei Su
This network shows the impact of papers produced by Beibei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beibei Su. The network helps show where Beibei Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Beibei Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 134 | |
| 2 | 2022 | 89 | |
| 3 | 2020 | 40 | |
| 4 | 2016 | 35 | |
| 5 | 2016 | 34 | |
| 6 | 2014 | 31 | |
| 7 | 2022 | 18 | |
| 8 | 2016 | 12 | |
| 9 | 2018 | 12 | |
| 10 | 2018 | 10 | |
| 11 | 2017 | 8 | |
| 12 | 2016 | 6 | |
| 13 | 2022 | 6 | |
| 14 | 2019 | 2 |
About Beibei Su
Beibei Su is a scholar working on Cancer Research, Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine and Neurology, having authored 14 papers that have together received 437 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Head and Neck Cancer Studies (2 papers), HER2/EGFR in Cancer Research (2 papers), Gastric Cancer Management and Outcomes (2 papers), Cancer-related molecular mechanisms research (2 papers), Immune cells in cancer (1 paper), Cancer Cells and Metastasis (1 paper) and Brain Metastases and Treatment (1 paper). The work is most often cited by research in Cancer Research (123 citations), Oncology (80 citations), Neurology (24 citations), Periodontics (18 citations) and Pulmonary and Respiratory Medicine (68 citations). Beibei Su has collaborated with scholars based in China and Germany. Frequent co-authors include Xianglin Yuan, Yu Tong Jin, Han Yin, Bili Wu, Shuwei Zhou, Hu Han, Chaofan Liu, Lu Wang, Qi Mei and Jian Li. Their work appears in journals such as Head & Neck, Medical Oncology, Signal Transduction and Targeted Therapy, Oncotarget and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.